AMG-172
Renal Cell Adenocarcinoma
Amgenantibody_drug_conjugatePhase 1
—
Rating in progress
AMG-172 in Renal Cell Adenocarcinoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Dormant